uniprot:Q9Y6Q6 in Computationally mapped citations

1 - 25 of 108 results for uniprot:Q9Y6Q6 in Computationally mapped citations

Results Customize

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Genetic Factors for Osteoporosis (GEFOS) Consortium Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Richards J.B., Zillikens M.C., Kavvoura F.K., Amin N., Aulchenko Y.S. et al. Nat. Genet. 41:1199-1206(2009) GAD 599869 · Mapped (122) Associated with METABOLIC: Bone mineral density (spine); GAD 599869
Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. Whyte M.P., Hughes A.E. J. Bone Miner. Res. 17:26-29(2002) GeneRIF 8792 · Mapped (6) Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication (84dup15) in TNFRSF11A encoding RANK. GeneRIF 8792
Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. Lossdorfer S., Gotz W., Jager A. Calcif. Tissue Int. 71:45-52(2002) GeneRIF 8792 · Mapped (9) immunohistochemical localization of this protein and its ligand in deciduous teeth GeneRIF 8792
Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. Abe M., Hiura K., Wilde J., Moriyama K., Hashimoto T., Ozaki S., Wakatsuki S., Kosaka M., Kido S., Inoue D. et al. Blood 100:2195-2202(2002) GeneRIF 8792 · Mapped (33) MIP-1alpha and MIP-1beta induce expression of RANK ligand by stromal cells thereby stimulating osteoclast differentiation of preosteoclastic cells. GeneRIF 8792
TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. Lee S.W., Han S.I., Kim H.H., Lee Z.H. J. Biochem. Mol. Biol. 35:371-376(2002) GeneRIF 8792 · Mapped (15) TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. GeneRIF 8792
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. Palenzuela L., Vives-Bauza C., Fernandez-Cadenas I., Meseguer A., Font N., Sarret E., Schwartz S., Andreu A.L. J. Med. Genet. 39:E67-E67(2002) GeneRIF 8792 · Mapped (6) Analysis of a large Spanish kindred confirms that exon 1 contains an insertional mutation in the RANK gene. GeneRIF 8792
Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Cremer I., Dieu-Nosjean M.C., Marechal S., Dezutter-Dambuyant C., Goddard S., Adams D., Winter N., Menetrier-Caux C., Sautes-Fridman C., Fridman W.H. et al. Blood 100:3646-3655(2002) GeneRIF 8792 · Mapped (9) Long-lived immature dendritic cells mediated by TRANCE-RANK interaction GeneRIF 8792
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. Johnson-Pais T.L., Singer F.R., Bone H.G., McMurray C.T., Hansen M.F., Leach R.J. J. Bone Miner. Res. 18:376-380(2003) GeneRIF 8792 · Mapped (6) a tandem duplication in exon 1 of the TNFRSF11A gene may have a role in familial expansile osteolysis GeneRIF 8792
Genetic predisposition to external apical root resorption in orthodontic patients: linkage of chromosome-18 marker. Al-Qawasmi R.A., Hartsfield J.K. Jr., Everett E.T., Flury L., Liu L., Foroud T.M., Macri J.V., Roberts W.E. J. Dent. Res. 82:356-360(2003) GeneRIF 8792 · Mapped (6) associated with external apical root resorption GeneRIF 8792
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. Nakatsuka K., Nishizawa Y., Ralston S.H. J. Bone Miner. Res. 18:1381-1385(2003) GeneRIF 8792 · Mapped (6) the 75dup27 mutation causes a Paget's disease of bone-like phenotype GeneRIF 8792
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. Karsdal M.A., Hjorth P., Henriksen K., Kirkegaard T., Nielsen K.L., Lou H., Delaisse J.M., Foged N.T. J. Biol. Chem. 278:44975-44987(2003) GeneRIF 8792 · Mapped (12) transforming growth factor-beta promotes osteoclastogenesis in monocytes by stimulation of the p38 mitogen activated protein kinase but continuous exposure abrogates osteoclastogenesis by down-regulation of receptor activator of NF-KB(RANK) expression GeneRIF 8792
Expression and function of RANK in human monocyte chemotaxis. Mosheimer B.A., Kaneider N.C., Feistritzer C., Sturn D.H., Wiedermann C.J. Arthritis Rheum. 50:2309-2316(2004) GeneRIF 8792 · Mapped (6) These data suggest that RANK is expressed by monocytes whose activation by RANKL stimulates directed migration involving phosphatidylinositol 3-kinase phosphodiesterase and Src kinases. GeneRIF 8792
Identification of single nucleotide polymorphisms in the tumor necrosis factor (TNF) and TNF receptor superfamily in the Korean population. Cho S.M., Kim J., Ryu H.J., Kim J.J., Kim H.H., Park J.H., Kim H.T., Kim K.H., Cho H.Y., Oh B. et al. Hum. Immunol. 65:710-718(2004) GeneRIF 8792 · Mapped (74) Observational study of genotype prevalence. (HuGE Navigator) GeneRIF 8792
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment. Giuliani N., Colla S., Morandi F., Rizzoli V. Haematologica 89:1118-1123(2004) GeneRIF 8792 · Mapped (17) RANK is expressed in bone marrow stroma cells & endothelial cells but not myeloma cells. It is involed in IL-6 & IL-11 secretion. GeneRIF 8792
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Collin-Osdoby P. Circ. Res. 95:1046-1057(2004) GeneRIF 8792 · Mapped (18) Review. The RANKL/RANK/OPG system may mediate links between the vascular skeletal & immune systems and play a central role in regulating the vascular calcification coincident with declines in skeletal mineralization with age osteoporosis or disease. GeneRIF 8792
Bone cancer pain and the role of RANKL/OPG. Clohisy D.R., Mantyh P.W. J Musculoskelet Neuronal Interact 4:293-300(2004) GeneRIF 8792 · Mapped (9) disruption of the RANKL-RANK axis with OPG inhibited tumor-induced osteoclastogenesis and decreased bone cancer pain. GeneRIF 8792
RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Page G., Miossec P. Arthritis Rheum. 52:2307-2312(2005) GeneRIF 8792 · Mapped (9) Involvement of RANK/RANKL in dendritic cell-T cell interactions during inflammatory process. RANK expression appears to be limited to sites of immune reaction both in synovium and in lymph nodes. GeneRIF 8792
The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Kwon O.H., Lee C.K., Lee Y.I., Paik S.G., Lee H.J. Biochem. Biophys. Res. Commun. 335:437-446(2005) GeneRIF 8792 · Mapped (13) PU.1 regulates RANK gene transcription; this may represent one of the key roles of PU.1 in osteoclast differentiation GeneRIF 8792
Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Choi J.Y., Shin A., Park S.K., Chung H.W., Cho S.I., Shin C.S., Kim H., Lee K.M., Lee K.H., Kang C. et al. Calcif. Tissue Int. 77:152-159(2005) GeneRIF 8792 · Mapped (63) Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) GeneRIF 8792
Functional dissection of osteoprotegerin and its interaction with receptor activator of NF-kappaB ligand. Schneeweis L.A., Willard D., Milla M.E. J. Biol. Chem. 280:41155-41164(2005) GeneRIF 8792 · Mapped (9) OPG dimer formation is required for the mechanism of inhibition of the RANK-L/RANK receptor interaction GeneRIF 8792
Anti-RANKL therapy for inflammatory bone disorders: Mechanisms and potential clinical applications. Anandarajah A.P., Schwarz E.M. J. Cell. Biochem. 97:226-232(2006) GeneRIF 8792 · Mapped (10) We review the etiology of inflammatory bone loss the RANK/RANK-ligand/OPG pathway and the clinical development of anti-RANK-ligand therapy. GeneRIF 8792
Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hsu Y.H., Niu T., Terwedow H.A., Xu X., Feng Y., Li Z., Brain J.D., Rosen C.J., Laird N., Xu X. Hum. Genet. 118:568-577(2006) GeneRIF 8792 GAD 136934 · Mapped (7) Associated with METABOLIC: bone density; GAD 136934 Observational study of gene-disease association. (HuGE Navigator) GeneRIF 8792
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero P., Corallini F., Barbarotto E., Melloni E., di Iasio M.G., Tiribelli M., Zauli G. J. Cell. Physiol. 207:158-164(2006) GeneRIF 8792 · Mapped (10) By upregulating IL-8 the RANKL/RANK system may contribute to the pathogenesis of B chronic lymphocytic leukemia. GeneRIF 8792
RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells. Wittrant Y., Lamoureux F., Mori K., Riet A., Kamijo A., Heymann D., Redini F. Int. J. Oncol. 28:261-269(2006) GeneRIF 8792 · Mapped (6) a functional RANK expressed on osteosarcoma cells GeneRIF 8792
Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Kim D., Cho S.W., Her S.J., Yang J.Y., Kim S.W., Kim S.Y., Shin C.S. Stem Cells 24:1798-1805(2006) GeneRIF 8792 · Mapped (6) Expression of RANK-Fc by genetically modified Mesenchymal stem cells may be a feasible option for the prevention of bone loss induced by ovariectomy. GeneRIF 8792

Results Customize

Rows